Key result
Patients with Alzheimer's dementia and mild cognitive impairment showed higher cerebral autoregulation during orthostatic challenges than controls.
Why the study?
Are cerebral autoregulation and baroreflex sensitivity impaired in patients with dementia and mild cognitive impairment due to Alzheimer disease compared to controls?
Observational (n=137)
Are cerebral autoregulation and baroreflex sensitivity impaired in patients with dementia and mild cognitive impairment due to Alzheimer disease compared to controls?
Answers are grounded in this paper and cite their sources.
Cerebral autoregulation and baroreflex sensitivity are preserved in patients with mild cognitive impairment and dementia due to Alzheimer disease, suggesting these mechanisms do not inherently increase the risks of antihypertensive treatment in this population.
Cerebral autoregulation and baroreflex sensitivity are key mechanisms that maintain cerebral blood flow. This study assessed whether these control mechanisms are affected in patients with dementia and mild cognitive impairment due to Alzheimer disease, as this would increase the risks of antihypertensive treatment. We studied 53 patients with dementia (73.1 years [95% confidence interval (CI), 71.4–74.8]), 37 patients with mild cognitive impairment (69.2 years [95% CI, 66.4–72.0]), and 47 controls (69.4 years [95% CI, 68.3–70.5]). Beat-to-beat blood pressure (photoplethysmography), heart rate, and cerebral blood flow velocity (transcranial Doppler) were measured during 5-minute rest (sitting) and 5 minutes of orthostatic challenges, using repeated sit-to-stand maneuvers. Cerebral autoregulation was assessed using transfer function analysis and the autoregulatory index. Baroreflex sensitivity was estimated with transfer function analysis and by calculating the heart rate response to blood pressure changes during the orthostatic challenges. Dementia patients had the lowest cerebral blood flow velocity ( P =0.004). During rest, neither transfer function analysis nor the autoregulatory index indicated impairments in cerebral autoregulation. During the orthostatic challenges, higher autoregulatory index ( P =0.011) and lower transfer function gain ( P =0.017), indicating better cerebral autoregulation, were found in dementia (4.56 arb. unit [95% CI, 4.14–4.97]; 0.59 cm/s per mm Hg [95% CI, 0.51–0.66]) and mild cognitive impairment (4.59 arb. unit [95% CI, 4.04–5.13]; 0.51 cm/s per mm Hg [95% CI, 0.44–0.59]) compared with controls (3.71 arb. unit [95% CI, 3.35–4.07]; 0.67 cm/s per mm Hg [95% CI, 0.59–0.74]). Baroreflex sensitivity measures did not differ between groups. In conclusion, the key mechanisms to control blood pressure and cerebral blood flow are not reduced in 2 stages of Alzheimer disease compared with controls, both in rest and during orthostatic changes that reflect daily life challenges.
No takes yet. Share an insight, caveat, or question.
Heus et al. (2018) conducted an observational in Alzheimer disease (dementia and mild cognitive impairment) (n=137). Orthostatic challenges (repeated sit-to-stand maneuvers) vs. Healthy controls was evaluated on Autoregulatory index during orthostatic challenges (p=0.011). Patients with Alzheimer's dementia and mild cognitive impairment showed higher cerebral autoregulation during orthostatic challenges than controls.
Synapse has enriched 10 related papers. Consider them for comparative context: